文献速递垂体与肾上腺疾病性腺与生殖内分泌

长读长测序解决大型21-羟化酶缺陷队列中CYP21A2的复杂结构

Long-Read Sequencing Solves Complex Structure of CYP21A2 in a Large 21-Hydroxylase Deficiency Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在832例21-羟化酶缺陷症(21-OHD)患者中,常规方法为81.7%(680/832)的病例提供了精确分子诊断,长读长测序(LRS)用于解决剩余144例复杂嵌合变异和8例多拷贝变异。LRS联合既往遗传学结果共识别16.9%(281/1664)的CYP21A1P/CYP21A2或TNXA/TNXB嵌合等位基因,CAH-X患病率为12.1%。结论认为LRS可检测所有类型的CYP21A2变异,可作为先天性肾上腺皮质增生症精准诊断与分型的一线常规检测。

要点

  • LRS可检测21-OHD患者中复杂嵌合及多拷贝上的致病性CYP21A2变异。
  • 832例中常规方法精确诊断81.7%(680/832),LRS解决144例复杂嵌合及8例多拷贝变异。
  • CAH-X患病率12.1%,CAH-X患者中结缔组织相关症状频率高。

核心结论

  • LRS可检测21-OHD患者所有类型的CYP21A2变异,包括复杂嵌合及多拷贝上的致病性变异。
  • LRS可作为先天性肾上腺皮质增生症精准诊断与分型的一线常规检测。

研究设计与样本

  • 研究纳入832例21-OHD患者队列,常规方法为81.7%(680/832)的病例提供精确分子诊断。
  • 对剩余144例复杂嵌合变异患者和8例多拷贝变异患者行长读长测序(LRS)。
  • 进一步评估CYP21A2连续缺失延伸至TNXB(即CAH-X)患者的临床表现。

主要发现

  • LRS联合既往遗传学检测结果,在832例患者中识别16.9%(281/1664)的CYP21A1P/CYP21A2或TNXA/TNXB嵌合等位基因。
  • CYP21A1P/CYP21A2嵌合占10.4%,TNXA/TNXB嵌合占6.5%。
  • 最常见3种嵌合为CYP21 CH-1、TNX CH-1和TNX CH-2,占所有嵌合等位基因的77.2%(217/281)。
  • 8例CYP21A2多拷贝变异患者经LRS被准确识别。
  • 本队列CAH-X患病率为12.1%,CAH-X患者中观察到结缔组织相关症状频率高。

临床怎么用

  • 作者结论认为LRS可作为先天性肾上腺皮质增生症精准诊断与分型的一线常规检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Genetic testing for 21-hydroxylase deficiency (21-OHD) is always challenging. The current approaches of short-read sequencing and multiplex ligation-dependent probe amplification (MLPA) are insufficient for the detection of chimeric genes or complicated variants from multiple copies. Recently developed long-read sequencing (LRS) can solve this problem. OBJECTIVE: To investigate the clinical utility of LRS in precision diagnosis of 21-OHD. METHODS: In the cohort of 832 patients with 21-OHD, the current approaches provided the precise molecular diagnosis for 81.7% (680/832) of cases. LRS was performed to solve the remaining 144 cases with complex chimeric variants and 8 cases with variants from multiple copies. Clinical manifestations in patients with continuous deletions of CYP21A2 extending to TNXB (namely CAH-X) were further evaluated. RESULTS: Using LRS in combination with previous genetic test results, a total of 16.9% (281/1664) CYP21A1P/CYP21A2 or TNXA/TNXB chimeric alleles were identified in 832 patients, with CYP21A1P/CYP21A2 accounting for 10.4% and TNXA/TNXB for 6.5%. The top 3 common chimeras were CYP21 CH-1, TNX CH-1, and TNX CH-2, accounting for 77.2% (217/281) of all chimeric alleles. The 8 patients with variants on multiple copies of CYP21A2 were accurately identified with LRS. The prevalence of CAH-X in our cohort was 12.1%, and a high frequency of connective tissue-related symptoms was observed in CAH-X patients. CONCLUSION: LRS can detect all types of CYP21A2 variants, including complex chimeras and pathogenic variants on multiple copies in patients with 21-OHD, which could be utilized as a first-tier routine test for the precision diagnosis and categorization of congenital adrenal hyperplasia.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wang R, Luo X, Sun Y, et al. Long-Read Sequencing Solves Complex Structure of CYP21A2 in a Large 21-Hydroxylase Deficiency Cohort. J Clin Endocrinol Metab. 2025. PMID: 39049755. doi:10.1210/clinem/dgae519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。